- Home
- / EVOQ Remedies
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
EVOQ Remedies financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₹9.2
2024-08-23
Revenue
₹117.6 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 23, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| INR | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 32.5M | 90.7M | 100.2M | 167.8M | 203.9M | 40.5M | 117.6M |
| Cost of goods sold | 32.3M | 90.5M | 78.5M | 137.7M | 193.3M | 15.6M | 130.8M |
| Gross profit | 226.0K | 256.0K | 21.7M | 30.1M | 70.8M | 47.5M | 10.9M |
| Gross profit margin, % | 0.7% | 0.3% | 21.7% | 17.9% | 34.7% | 117.3% | 9.3% |
| Operating expense total | 64.0K | 249.0K | 12.2M | 15.5M | 47.9M | 41.3M | 9.1M |
| Depreciation and amortization | 39.0K | 73.0K | 489.0K | ||||
| EBITDA | 162.0K | 7.0K | 9.5M | 14.6M | 22.9M | 6.2M | 1.8M |
| EBITDA margin, % | 0.5% | 0.0% | 9.5% | 8.7% | 11.2% | 15.3% | 1.5% |
| EBIT | 162.0K | 7.0K | 9.5M | 14.6M | 22.9M | 6.1M | 1.3M |
| EBIT margin, % | 0.5% | 0.0% | 9.5% | 8.7% | 11.2% | 15.1% | 1.1% |
| Interest expense | 2.0K | 2.0K | 2.0K | 46.0K | 13.0K | 1.0K | |
| Pre tax profit | 160.0K | 5.0K | 9.5M | 14.6M | 22.8M | 6.1M | 1.3M |
| Income tax expense | 49.0K | 2.0K | 2.4M | 3.7M | 6.7M | 1.6M | 400.0K |
| Net Income | 111.0K | 3.0K | 7.1M | 10.9M | 16.2M | 4.5M | 882.0K |